FDA Approvals in Oncology: April-June 2026
During the second quarter of 2026, oncology approvals issued by the U.S. Food and Drug Administration expanded the treatment...
Tag: Breast cancer
During the second quarter of 2026, oncology approvals issued by the U.S. Food and Drug Administration expanded the treatment...
In May, AACR's journals editors highlighted studies on CD28’s impact on CAR T-cell activity, the relationship between neurons and...
In April 2026, AACR's journals editors highlighted studies on cancer survivors taking GLP-1 agonists, an immunotherapy-boosting bacteria, and more.
In March, AACR's journals editors highlighted studies on the development of pediatric leukemia, the use of low-dose tamoxifen, and...
In February, the editors of AACR's journals highlighted studies on the FDA’s accelerated approval pathway, how metabolism impacts prostate...
Researchers and a patient advocate weighed in on current and emerging treatment options for each stage of triple-negative breast...
In the last quarter of 2025, the FDA announced 20 approvals in oncology, including treatments for lung cancer, multiple...
At the SABCS 2025 View From the Trenches session, experts discussed how new clinical trial results might transform breast...
At SABCS 2025, studies show some patients with early-stage breast cancer can skip steps like SLNB or MRI without...
In clinical trials presented at SABCS, a mobile health tool and acupuncture helped to improve breast cancer survivors' quality...